We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+10.98%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$21.7B
AUM Growth
+$1.52B
Cap. Flow
-$396M
Cap. Flow %
-1.83%
Top 10 Hldgs %
30.74%
Holding
733
New
39
Increased
433
Reduced
235
Closed
15

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$84.2M
2
SYT
Syngenta Ag
SYT
+$72.8M
3
NOV icon
NOV
NOV
+$66.8M
4
DE icon
Deere & Co
DE
+$66.6M
5
POT
Potash Corp Of Saskatchewan
POT
+$66.4M

Sector Composition

Rank Sector Weight
1 Materials 45.09%
2 Energy 26.66%
3 Healthcare 4.74%
4 Industrials 3.46%
5 Consumer Staples 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHPG
176
DELISTED
Shire pic
SHPG
$14.2M 0.07%
60,152
-8,248
-12% -$1.43M
AVGO icon
177
Broadcom
AVGO
$1.82T
$13.5M 0.06%
1,869,870
+9,770
+0.5% +$65.6K
GSS
178
DELISTED
Golden Star Resources Ltd.
GSS
$13.2M 0.06%
4,488,543
+328,533
+8% +$943K
ALKS icon
179
Alkermes
ALKS
$8.82B
$12.9M 0.06%
256,361
-359,936
-58% -$16.6M
SQM icon
180
Sociedad Química y Minera de Chile
SQM
$19.6B
$12.8M 0.06%
448,048
-133,435
-23% -$3.97M
DRD
181
DRDGold
DRD
$1.82B
$12.8M 0.06%
4,293,715
+706,875
+20% +$2.14M
TSLA icon
182
Tesla
TSLA
$1.24T
$12.6M 0.06%
790,245
+99,885
+14% +$1.39M
XLNX
183
DELISTED
Xilinx Inc
XLNX
$12M 0.06%
252,944
-2,642
-1% -$127K
VALE icon
184
Vale
VALE
$62.9B
$11.9M 0.06%
902,864
-114,957
-11% -$1.55M
AGN
185
DELISTED
Allergan plc
AGN
$11.9M 0.06%
53,433
-9,510
-15% -$1.97M
CBST
186
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$11.6M 0.05%
166,302
-28,400
-15% -$1.93M
RIO icon
187
Rio Tinto
RIO
$148B
$11.6M 0.05%
213,552
-32,114
-13% -$1.74M
NRF
188
DELISTED
NorthStar Realty Finance Corp.
NRF
$11.1M 0.05%
324,247
+67,366
+26% +$2.12M
ETN icon
189
Eaton
ETN
$157B
$11M 0.05%
143,094
-7,755
-5% -$576K
BHC icon
190
Bausch Health
BHC
$1.65B
$10.9M 0.05%
86,546
-11,942
-12% -$1.52M
WOLF icon
191
Wolfspeed
WOLF
$1.2B
$10.9M 0.05%
217,289
-26,682
-11% -$1.33M
JOY
192
DELISTED
Joy Global Inc
JOY
$10.8M 0.05%
175,798
+2,251
+1% +$135K
OIS icon
193
Oil States International
OIS
$522M
$10.8M 0.05%
167,972
-132,421
-44% -$7.79M
BAA
194
DELISTED
Banro Corporation Common Stock
BAA
$10.6M 0.05%
+2,214,212
New +$10.1M
CVD
195
DELISTED
COVANCE INC.
CVD
$10.5M 0.05%
122,636
-18,061
-13% -$1.61M
MDR
196
DELISTED
McDermott International
MDR
$10.2M 0.05%
420,364
+44,753
+12% +$983K
LRCX icon
197
Lam Research
LRCX
$382B
$9.94M 0.05%
1,470,660
-26,390
-2% -$158K
UTHR icon
198
United Therapeutics
UTHR
$26.3B
$9.84M 0.05%
111,143
-26,770
-19% -$2.57M
MMYT icon
199
MakeMyTrip
MMYT
$4.67B
$9.39M 0.04%
267,242
+174,067
+187% +$4.43M
KLAC icon
200
KLA
KLAC
$275B
$9.36M 0.04%
1,288,250
-51,100
-4% -$339K

Similar funds

VanEck Associates's Q2 2014 Portfolio in Review

As of Q2 2014, VanEck Associates held 733 positions worth $21.7B, up 7.6% from $20.1B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

VanEck Associates's Q2 2014 filing shows 39 new, 433 increased, 235 reduced and 15 closed positions. Its largest new stake was MAG Silver: 5,536,686 shares worth $52.4M. The largest sale was Monsanto Co, an estimated $84.2M.

By sector, the portfolio is most concentrated in Materials at 45% of assets, up from 45% a quarter earlier, followed by Energy and Healthcare.

  • VanEck Associates's largest Q2 2014 buy was MAG Silver: 5,536,686 shares worth $52.4M.
  • VanEck Associates added most to Yamana Gold, Inc. in Q2 2014, an estimated $110M increase.
  • VanEck Associates's biggest Q2 2014 reduction was Monsanto Co, cutting an estimated $84.2M.
  • VanEck Associates fully exited Weatherford International plc in Q2 2014, selling an estimated $45.6M.
  • VanEck Associates's ten largest holdings make up 31% of its $21.7B portfolio in Q2 2014.
  • VanEck Associates opened 39 new positions and closed 15 in Q2 2014.
  • VanEck Associates's portfolio value rose 7.6% quarter-over-quarter to $21.7B.

Based on VanEck Associates's 13F filing for Q2 2014, filed 14 Aug 2014.